BRIEF-UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force

Reuters
05 May
BRIEF-UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force

May 5 (Reuters) - UNITY Biotechnology Inc UBX.O:

  • UNITY BIOTECHNOLOGY INC - COMPANY ESTIMATES $3.7 MILLION CASH EXPENSES FOR REDUCTION IN FORCE - SEC FILING

  • UNITY BIOTECHNOLOGY INC - REDUCTION IN FORCE EXPECTED TO BE COMPLETED BY MAY 15, 2025 - SEC FILING

  • UNITY BIOTECHNOLOGY INC - CEO ANIRVAN GHOSH, CFO LYNNE SULLIVAN, AND ALEXANDER NGUYEN TO TERMINATE EMPLOYMENT - SEC FILING

Source text: [ID:n0000950170-25-063167]

Further company coverage: UBX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10